000 01659 a2200445 4500
005 20250515132706.0
264 0 _c20080915
008 200809s 0 0 eng d
022 _a1527-1315
024 7 _a10.1148/radiol.2483072231
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWillmann, Jürgen K
245 0 0 _aDual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
_h[electronic resource]
260 _bRadiology
_cSep 2008
300 _a936-44 p.
_bdigital
500 _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aContrast Media
_xmetabolism
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImage Enhancement
650 0 4 _aIntegrin alphaVbeta3
_xmetabolism
650 0 4 _aMicrobubbles
650 0 4 _aNeovascularization, Pathologic
_xdiagnostic imaging
650 0 4 _aOvarian Neoplasms
_xblood supply
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aUltrasonography
650 0 4 _aVascular Endothelial Growth Factor Receptor-2
_xmetabolism
700 1 _aLutz, Amelie M
700 1 _aPaulmurugan, Ramasamy
700 1 _aPatel, Manishkumar R
700 1 _aChu, Pauline
700 1 _aRosenberg, Jarrett
700 1 _aGambhir, Sanjiv S
773 0 _tRadiology
_gvol. 248
_gno. 3
_gp. 936-44
856 4 0 _uhttps://doi.org/10.1148/radiol.2483072231
_zAvailable from publisher's website
999 _c18183526
_d18183526